{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:34:51Z","timestamp":1760204091366},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf02072029","type":"journal-article","created":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T11:32:20Z","timestamp":1124019140000},"page":"1-17","source":"Crossref","is-referenced-by-count":47,"title":["Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood"],"prefix":"10.1007","volume":"67","author":[{"given":"Reinhard","family":"Neubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diether","family":"Neubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02072029_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.me.38.020187.001135","volume":"38","author":"DC Anderson","year":"1987","unstructured":"Anderson DC, Springer TA (1987) Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and P150,95 glycoproteins. Ann Rev Med 38: 175\u2013194","journal-title":"Ann Rev Med"},{"key":"BF02072029_CR2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0190-9622(86)80357-7","volume":"14","author":"IK Aronson","year":"1986","unstructured":"Aronson IK, Weber L, West D, Buys C, Reder A, Antel J (1986) Thalidomide and lymphocyte function. J Am Acad Dermatol 14: 282\u2013283","journal-title":"J Am Acad Dermatol"},{"key":"BF02072029_CR3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/S0036-46651986000100003","volume":"28","author":"WO Arruda","year":"1986","unstructured":"Arruda WO, Hacbarth E, Dol E, Santa-Maria JR, Barbosa J, Kajdacsy-Balla AA (1986) Efeito da talidomida sobre os niveis sericos de immunoglobulinas IgM e IgA, fator reumatoide e isohemaglutinina anti-A e anti-B em patientes com lepra lepromatosa. Urn estudo duplo-cego. Rev Inst Med Trop Sao Paulo 28: 12\u201314","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"BF02072029_CR4","first-page":"131","volume":"19","author":"J Barba-Rubio","year":"1975","unstructured":"Barba-Rubio J, Franco-Gonzalez F (1975) Lupus eritematoso discoide y talidomida. Dermatol Rev Mex 19: 131","journal-title":"Dermatol Rev Mex"},{"key":"BF02072029_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0190-9622(82)70118-5","volume":"7","author":"RL Barnhill","year":"1982","unstructured":"Barnhill RL, McDougall AC (1982) Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol 7: 317\u2013323","journal-title":"J Am Acad Dermatol"},{"key":"BF02072029_CR6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00007890-198903000-00014","volume":"47","author":"D Baume","year":"1989","unstructured":"Baume D, Kuentz M, Pico J-L, Beaujean F, Cordonnier C, Vernant JP, Hayat M, Bernard A (1989) Failure of a CD18\/anti-LFAl monoclonal antibody infusion to prevent graft rejection in leukemic patients receiving T-depleted allogeneic bone marrow transplantation. Transplantation 47: 472\u2013474","journal-title":"Transplantation"},{"key":"BF02072029_CR7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0140-6736(92)90365-A","volume":"339","author":"D Bessis","year":"1992","unstructured":"Bessis D, Guillot B, Montpoint S, Dandurand M, Guilhou JJ (1992) Thalidomide for systemic lupus erythematosus. Lancet 339: 549\u2013550","journal-title":"Lancet"},{"issue":"Suppl 97","key":"BF02072029_CR8","first-page":"77","volume":"21","author":"A B\u00f6yum","year":"1968","unstructured":"B\u00f6yum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 [Suppl 97]: 77\u201379","journal-title":"Scand J Clin Lab Invest"},{"key":"BF02072029_CR9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0006-2952(84)90415-5","volume":"33","author":"AG Braun","year":"1984","unstructured":"Braun AG, Weinreb SL (1984) Teratogen metabolism: activation of thalidomide and thalidomide analogues to products that inhibit the attachment of cells to concanavalin A coated plastic surfaces. Biochem Pharmacol 33: 1471\u20131477","journal-title":"Biochem Pharmacol"},{"key":"BF02072029_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/eji.1830200216","volume":"20","author":"A-M Buckle","year":"1990","unstructured":"Buckle A-M, Hogg N (1990) Human memory T cells express intercellular adhesion molecule-1 which can be increased by interleukin 2 and interferon-\u03b3. Eur J Immunol 20: 337\u2013341","journal-title":"Eur J Immunol"},{"key":"BF02072029_CR11","first-page":"402","volume":"17","author":"T-L Chen","year":"1989","unstructured":"Chen T-L, Vogelsang GB, Petty BG, Brundrett RB, Noe DA, Santos GW, Colvin OM (1989) Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers. Drug Metabol Dispos 17: 402\u2013405","journal-title":"Drug Metabol Dispos"},{"key":"BF02072029_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(87)92924-2","volume":"II","author":"C Clayberger","year":"1987","unstructured":"Clayberger C, Medeiros LJ, Link MP, Warnke RA, Wright A, Koller TD, Smith SD, Krensky AM (1987) Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet II: 533\u2013536","journal-title":"Lancet"},{"key":"BF02072029_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archderm.1984.01650390060012","volume":"120","author":"OJ Clemmensen","year":"1984","unstructured":"Clemmensen OJ, Olsen PZ, Andersen KE (1984) Thalidomide neurotoxicity. Arch Dermatol 120: 338\u2013341","journal-title":"Arch Dermatol"},{"key":"BF02072029_CR14","first-page":"241","volume":"7","author":"AS Coulson","year":"1970","unstructured":"Coulson AS, Summers LJ, Lindahl-Kiessling K, Tucker D, Hellmann K (1970) The effect of two soluble thalidomide derivatives on lymphocyte stimulation. Clin Exp Immunol 7: 241\u2013247","journal-title":"Clin Exp Immunol"},{"key":"BF02072029_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0030-4220(87)90006-5","volume":"64","author":"L Eisenbud","year":"1987","unstructured":"Eisenbud L, Horowitz I, Kay B (1987) Recurrent aphthous stomatitis of the Beh\u00e7et's type: successful treatment with thalidomide. Oral Surg Oral Med Oral Pathol 64: 289\u2013292","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"BF02072029_CR16","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/2111308a0","volume":"211","author":"EO Field","year":"1966","unstructured":"Field EO, Gibbs JE, Tucker DF, Hellmann K (1966) Effect of thalidomide on the graft-vs-host reaction. Nature 211: 1308\u20131310","journal-title":"Nature"},{"key":"BF02072029_CR17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(86)90465-4","volume":"II","author":"A Fischer","year":"1986","unstructured":"Fischer A, Blanche S, Veber F, Delaage M, Mavas C, Griscelli C, LeDeist F, Lopez M, Olive D, Janossy G (1986) Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation. Lancet II: 1058\u20131061","journal-title":"Lancet"},{"key":"BF02072029_CR18","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1136\/bmj.2.5217.1954","volume":"2","author":"AL Florence","year":"1960","unstructured":"Florence AL (1960) Is thalidomide to blame? Br Med J 2: 1954","journal-title":"Br Med J"},{"key":"BF02072029_CR19","first-page":"613","volume":"32","author":"E Friderichs","year":"1982","unstructured":"Friderichs E (1982) Untersuchungen zum ZNS-Wirkprofil von Thalidomid-Analoga. Arzneimittelforschung 32: 613\u2013620","journal-title":"Arzneimittelforschung"},{"key":"BF02072029_CR20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/jnnp.31.6.543","volume":"31","author":"PM Fullerton","year":"1968","unstructured":"Fullerton PM, O'Sullivan DJ (1968) Thalidomide neuropathy: a clinical, electrophysiological, and histological follow-up study. J Neurol Neurosurg Psychiat 31: 543\u2013551","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"BF02072029_CR21","first-page":"35","volume":"56","author":"SM Gad","year":"1985","unstructured":"Gad SM, Shannon EJ, Krotoski WA, Hastings RC (1985) Thalidomide induces imbalance in T-lymphocyte sub-populations in the circulating blood of healthy males. Lepr Rev 56: 35\u201339","journal-title":"Lepr Rev"},{"key":"BF02072029_CR22","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1073\/pnas.78.4.2545","volume":"78","author":"GB Gordon","year":"1981","unstructured":"Gordon GB, Spielberg SP, Blake DA, Balasubrammanian V (1981) Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite. Proc Nat Acad Sci USA 78: 2545\u20132548","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF02072029_CR23","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0140-6736(90)91223-W","volume":"335","author":"I Gorin","year":"1990","unstructured":"Gorin I, Vilette B, Gehanno P, Escande JP (1990) Thalidomide in hyperalgic pharyngeal ulceration of AIDS. Lancet 335: 1343","journal-title":"Lancet"},{"key":"BF02072029_CR24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-4362.1984.tb05696.x","volume":"23","author":"E Grosshans","year":"1984","unstructured":"Grosshans E, Illy G (1984) Thalidomide therapy for inflammatory dermatoses. Int J Dermatol 23: 598\u2013602","journal-title":"Int J Dermatol"},{"key":"BF02072029_CR25","first-page":"1138","volume":"36","author":"V G\u00fcnzler","year":"1986","unstructured":"G\u00fcnzler V, Hanauske-Abel HM, Tschank G, Schulte-Wissermann H (1986) Immunological effects of thalidomide. Inactivity of the drug and several of its hydrolysis products in mononucleocyte proliferation tests. Arzneimittelforschung 36: 1138\u20131141","journal-title":"Arzneimittelforschung"},{"key":"BF02072029_CR26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4049\/jimmunol.140.3.693","volume":"140","author":"A Hamann","year":"1988","unstructured":"Hamann A, Jablonski-Westrich D, Duijvestijn A, Butcher EC, Baisch H, Harder R, Thiele H-G (1988) Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. J Immunol 140: 693\u2013699","journal-title":"J Immunol"},{"key":"BF02072029_CR27","first-page":"65","volume":"18","author":"RC Hastings","year":"1980","unstructured":"Hastings RC (1980) Kellersberger Memorial lecture 1979: immunosuppressive\/anti-inflammatory thalidomide analogues. Ethiop Med J 18: 65\u201371","journal-title":"Ethiop Med J"},{"key":"BF02072029_CR28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/cpt1970114481","volume":"11","author":"RC Hastings","year":"1970","unstructured":"Hastings RC, Trautman JR, Enna CD, Jacobson RR (1970) Thalidomide in the treatment of erythema nodosum leprosum, with a note on selected laboratory abnormalities in erythema nodosum leprosum. Clin Pharmacol Ther 11: 481\u2013487","journal-title":"Clin Pharmacol Ther"},{"key":"BF02072029_CR29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00570141","volume":"62","author":"W Heger","year":"1988","unstructured":"Heger W, Klug S, Schmahl H-J, Nau H, Merker H-J, Neubert D (1988) Embryotoxic effects of thalidomide derivatives on the non-human primateCallithrix jacchus. 3. Teratogenic potency of the EM12 enantiomers. Arch Toxicol 62: 205\u2013208","journal-title":"Arch Toxicol"},{"key":"BF02072029_CR30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(66)91144-5","volume":"I","author":"K Hellmann","year":"1966","unstructured":"Hellmann K (1966) Immunosuppression by thalidomide: implications for teratogenicity. Lancet I: 1136\u20131137","journal-title":"Lancet"},{"key":"BF02072029_CR31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/bmj.2.5463.687","volume":"2","author":"K Hellmann","year":"1965","unstructured":"Hellmann K, Duke DI, Tucker DF (1965) Prolongation of skin homograft survival by thalidomide. BMJ 2: 687\u2013689","journal-title":"BMJ"},{"key":"BF02072029_CR32","first-page":"941","volume":"31","author":"DC Helm","year":"1981","unstructured":"Helm DC, Frankus E, Friderichs E, Graudums I, Floh\u00e9 L (1981) Comparative teratological investigation of compounds structurally and pharmacologically related to thalidomide. Arzneimittelforschung 31: 941\u2013949","journal-title":"Arzneimittelforschung"},{"key":"BF02072029_CR33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0167-5699(88)91280-7","volume":"9","author":"ME Hemler","year":"1988","unstructured":"Hemler ME (1988) Adhesive protein receptors on hematopoietic cells. Immunol Today 9: 109\u2013113","journal-title":"Immunol Today"},{"key":"BF02072029_CR34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/tera.1420220206","volume":"22","author":"AG Hendrickx","year":"1980","unstructured":"Hendrickx AG, Helm FC (1980) Nonteratogenicity of a structural analog of thalidomide in pregnant baboons (Papio cynocephalus). Teratology 22: 179\u2013182","journal-title":"Teratology"},{"key":"BF02072029_CR35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0753-3322(90)90024-4","volume":"44","author":"D Heney","year":"1990","unstructured":"Heney D, Bailey CC, Lewis IJ (1990) Thalidomide in the treatment of graft-versus-host disease. Biomed Pharmacother 44: 199\u2013204","journal-title":"Biomed Pharmacother"},{"key":"BF02072029_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2141.1991.tb04377.x","volume":"78","author":"D Heney","year":"1991","unstructured":"Heney D, Norfolk DR, Wheeldon J, Bailey CC, Lewis IJ, Barnard DL (1991) Thalidomide treatment for chronic graft-versus-host disease. Br J Haematol 78: 23\u201327","journal-title":"Br J Haematol"},{"key":"BF02072029_CR37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(87)90233-9","volume":"48","author":"RO Hynes","year":"1987","unstructured":"Hynes RO (1987) Integrins: a family of cell surface receptors. Cell 48: 549\u2013554","journal-title":"Cell"},{"key":"BF02072029_CR38","first-page":"719","volume":"45","author":"CGS Iyer","year":"1971","unstructured":"Iyer CGS, Languillon J, Ramanujam K, Tarabine-Castellani G, Terencio de las Aguas J, Bechelli LM, Uemura K, Martinez Dominguez V, Sundaresan T (1971) WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients. Bull World Health Organ 45: 719\u2013732","journal-title":"Bull World Health Organ"},{"key":"BF02072029_CR39","first-page":"21","volume":"15","author":"AJ Jackson","year":"1980","unstructured":"Jackson AJ, Schumacher HJ (1980) Identification of urinary metabolites of EM12 N-(2\u2032,6\u2032-dioxopiperidin-3\u2032-yl)-phthalimidine, a teratogenic analogue of thalidomide in rats and rabbits. Can J Pharmaceut Sci 15: 21\u201323","journal-title":"Can J Pharmaceut Sci"},{"key":"BF02072029_CR40","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4049\/jimmunol.145.4.1181","volume":"145","author":"SC Johnston","year":"1990","unstructured":"Johnston SC, Dustin ML, Hibbs ML, Springer TA (1990) On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules. J Immunol 145: 1181\u20131187","journal-title":"J Immunol"},{"key":"BF02072029_CR41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2133.1983.tb04600.x","volume":"108","author":"J Knop","year":"1983","unstructured":"Knop J, Bonsmann G, Happel R, et al. (1983) Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol 108: 461\u2013466","journal-title":"Br J Dermatol"},{"key":"BF02072029_CR42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4049\/jimmunol.131.2.611","volume":"131","author":"AM Krensky","year":"1983","unstructured":"Krensky AM, Sanchez-Madrid F, Robbins E, Nagy JA, Springer TA, Burakoff SJ (1983) The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J Immunol 131: 611\u2013616","journal-title":"J Immunol"},{"key":"BF02072029_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/tera.1420380303","volume":"38","author":"W Lenz","year":"1988","unstructured":"Lenz W (1988) A short history of thalidomide embryopathy. Teratology 38: 203\u2013215","journal-title":"Teratology"},{"key":"BF02072029_CR44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/00039896.1962.10663250","volume":"5","author":"W Lenz","year":"1962","unstructured":"Lenz W, Knapp K (1962) Thalidomide embryopathy. Arch Envir Health 5: 100\u2013105","journal-title":"Arch Envir Health"},{"key":"BF02072029_CR45","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0753-3322(89)90089-9","volume":"43","author":"DM McCarthy","year":"1989","unstructured":"McCarthy DM, Kanfer EJ, Barrett AJ (1989) Thalidomide for therapy of graft-versus-host disease following allogeneic bone marrow transplantation. Biomed Pharmacother 43: 693\u2013697","journal-title":"Biomed Pharmacother"},{"key":"BF02072029_CR46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.137.1.108","volume":"137","author":"SJ Mentzer","year":"1986","unstructured":"Mentzer SJ, Faller DV, Burakoff SJ (1986) Interferon-\u03b3 induction of LFA-1-mediated homotypic adhesion of human monocytes. J Immunol 137: 108\u2013113","journal-title":"J Immunol"},{"key":"BF02072029_CR47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00316631","volume":"61","author":"H-J Merker","year":"1988","unstructured":"Merker H-J, Heger W, Sames K, St\u00fcrje H, Neubert D (1988) Embryotoxic effects of thalidomide derivatives on the non-human primateCallithrix jacchus. 1. Effects of 3-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-dioxopiperidine (EM12). Arch Toxicol 61: 165\u2013179","journal-title":"Arch Toxicol"},{"key":"BF02072029_CR48","first-page":"201","volume":"53","author":"B Moncada","year":"1985","unstructured":"Moncada B, Baranda ML, Gonzalez-Amaro R, Urbina R, Loredo CE (1985) Thalidomide, effect on T cell subsets as a possible mechanism of action. Int J Lepr Other Mycobact Dis 53: 201\u2013205","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"BF02072029_CR49","first-page":"177","volume-title":"Pharmacokinetics in teratogenesis, vol I. Interspecies differences and placental transfer","author":"D Neubert","year":"1987","unstructured":"Neubert D, Heger W, Bremer D, Frankus E, Helm F-C, Merker H-J (1987) Some studies on the areneoxide hypothesis of the teratogenic action of thalidomide. In: Nau H, Scott WJ (eds) Pharmacokinetics in teratogenesis, vol I. Interspecies differences and placental transfer. CRC, Boca Raton, pp 177\u2013179"},{"key":"BF02072029_CR50","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00316632","volume":"61","author":"D Neubert","year":"1988","unstructured":"Neubert D, Heger W, Merker H-J, Sames K, Meister R (1988) Embryotoxic effects of thalidomide derivatives on the non-human primateCallithrix jacchus. 2. Elucidation of the susceptible period and of the variability of embryonic stages. Arch Toxicol 61: 180\u2013191","journal-title":"Arch Toxicol"},{"key":"BF02072029_CR51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF01973455","volume":"64","author":"R Neubert","year":"1990","unstructured":"Neubert R, Jacob-M\u00fcller U, Stahlmann R, Helge H, Neubert D (1990) Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 1. Effects on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus) after treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Arch Toxicol 64: 345\u2013359","journal-title":"Arch Toxicol"},{"key":"BF02072029_CR52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/BF02307170","volume":"66","author":"R Neubert","year":"1991","unstructured":"Neubert R, Helge H, Jacob-M\u00fcller U, Stahlmann R, Neubert D (1991 a) Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 4. Effects of multiple-dose treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on peripheral lymphocyte subpopulations of a non-human primate (Callithrix jacchus). Arch Toxicol 66: 250\u2013259","journal-title":"Arch Toxicol"},{"issue":"Suppl 2","key":"BF02072029_CR53","first-page":"R123","volume":"344","author":"R Neubert","year":"1991","unstructured":"Neubert R, Nogueira AC, Neubert D (1991b) Effect of thalidomidederivatives on the pattern of lymphocyte subpopulations in marmoset blood. Naunyn Schmiedebergs Arch Pharmacol 344 [Suppl 2]: R123 (77) (abstract)","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"Suppl","key":"BF02072029_CR54","first-page":"R94","volume":"345","author":"R Neubert","year":"1992","unstructured":"Neubert R, Nogueira AC, Neubert D (1992 a) Thalidomide derivatives alter the expression of lymphocyte function-associated antigens in marmoset blood. Naunyn Schmiedebergs Arch Pharmacol 345 [Suppl]: R94 (375) (abstract)","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF02072029_CR55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-3-642-77753-0_24","volume-title":"Risk assessment of prenatally-induced adverse health effects","author":"R Neubert","year":"1992","unstructured":"Neubert R, Nogueira AC, Helge H, Stahlmann R, Neubert D (1992 b) Feasibility of studying effects on the immune system in non-human primates. In: Neubert D, Kavlock RJ, Merker H-J, Klein J (eds) Risk assessment of prenatally-induced adverse health effects. Springer, Berlin Heidelberg New York, pp 313\u2013346"},{"key":"BF02072029_CR56","doi-asserted-by":"crossref","unstructured":"Neubert R, Nogueira AC, Neubert D (1992 c) Thalidomide derivatives and the immune system. 2. Changes in receptors on blood cells of a healthy volunteer. Life Sciences (in press)","DOI":"10.1016\/0024-3205(92)90162-I"},{"key":"BF02072029_CR57","unstructured":"Neubert R, Helge H, Golor G, Neubert D (1992 d) Characterization of lymphocyte subpopulations in the venous blood of marmosets (Callithrix jacchus). J Med Primatol (in press)"},{"key":"BF02072029_CR58","first-page":"1954","volume":"24","author":"DP Nicolau","year":"1990","unstructured":"Nicolau DP, West TE (1990) Thalidomide: treatment of severe recurrent aphthous stomatitis in patients with AIDS. DICP Ann Pharmacother 24: 1954\u20131956","journal-title":"DICP Ann Pharmacother"},{"issue":"Suppl 2","key":"BF02072029_CR59","first-page":"R124","volume":"344","author":"AC Nogueira","year":"1991","unstructured":"Nogueira AC, Neubert R, Neubert D (1991) Thalidomide-induced alterations in marmoset lymphocytes in culture. Naunyn Schmiedebergs Arch Pharmacol 344 [Suppl 2]: R124 (82) (abstract)","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BF02072029_CR60","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.4049\/jimmunol.140.6.1851","volume":"140","author":"ST Pals","year":"1988","unstructured":"Pals ST, den Otter A, Miedema F, Kabel P, Keizer GD, Scheper RJ, Meijer CJLM (1988) Evidence that leukocyte function-associated antigen-1 is involved in recirculation and homing of human lymphocytes via high endothelial venules. J Immunol 140: 1851\u20131853","journal-title":"J Immunol"},{"key":"BF02072029_CR61","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(62)92596-5","volume":"II","author":"S Roath","year":"1962","unstructured":"Roath S, Elves MW, Israels MCG (1962) Effect of thalidomide on leukocyte cultures. Lancet II: 812\u2013813","journal-title":"Lancet"},{"key":"BF02072029_CR62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(63)90956-5","volume":"I","author":"S Roath","year":"1963","unstructured":"Roath S, Elves MW, Israels MCG (1963) Effect of thalidomide and its derivatives on human leukocytes cultured in vitro. Lancet I: 249\u2013250","journal-title":"Lancet"},{"key":"BF02072029_CR63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(86)90259-X","volume":"44","author":"E Ruoslahti","year":"1986","unstructured":"Ruoslahti E, Pierschbacher MD (1986) Arg-Gly-Asp: a versatile cell recognition signal. Cell 44: 517\u2013518","journal-title":"Cell"},{"key":"BF02072029_CR64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1126\/science.2821619","volume":"238","author":"E Ruoslahti","year":"1987","unstructured":"Ruoslahti E, Pierschbacher MD (1987) New perspectives in cell adhesion: RGD and integrins. Science 238: 491\u2013497","journal-title":"Science"},{"key":"BF02072029_CR65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1126\/science.3281256","volume":"240","author":"U Rutishauser","year":"1988","unstructured":"Rutishauser U, Acheson A, Hall AK, Mann DM, Sunshine J (1988) The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 240: 53\u201357","journal-title":"Science"},{"key":"BF02072029_CR66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJM199207163270319","volume":"327","author":"J Ryan","year":"1992","unstructured":"Ryan J, Colman J, Pedersen J, Benson E (1992) Thalidomide to treat esophageal ulcer in AIDS. N Engl J Med 327: 208\u2013209","journal-title":"N Engl J Med"},{"key":"BF02072029_CR67","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","volume":"173","author":"EP Sampaio","year":"1991","unstructured":"Sampaio EP, Sarno EN, Galilly R, Cohn ZA, Kaplan G (1991) Thalidomide selectively inhibits tumor necrosis factor a production by stimulated human monocytes. J Exp Med 173: 699\u2013703","journal-title":"J Exp Med"},{"key":"BF02072029_CR68","first-page":"515","volume":"107","author":"M Samsoen","year":"1980","unstructured":"Samsoen M, Grosshans E, Basset A (1980) La thalidomide dans le traitement du lupus \u00e9ryth\u00e9mateux chronique. Ann Dermatol Venereol 107: 515\u2013523","journal-title":"Ann Dermatol Venereol"},{"key":"BF02072029_CR69","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.140.5.1401","volume":"140","author":"ME Sanders","year":"1988","unstructured":"Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, Shaw S (1988) Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-\u03b3 production. J Immunol 140: 1401\u20131407","journal-title":"J Immunol"},{"key":"BF02072029_CR70","first-page":"181","volume-title":"Pharmacokinetics in teratogenesis, vol I. Interspecies differences and placental transfer","author":"H-J Schmahl","year":"1987","unstructured":"Schmahl H-J, Winckler K, Klinkm\u00fcller K, Heger W, Barrach H-J, Nau H (1987) Pharmacokinetics of the teratogenic and non-teratogenic thalidomide analogue EM12 and supidimide in the rat and marmoset monkey. In: Nau H, Scott WJ (eds) Pharmacokinetics in teratogenesis, vol I. Interspecies differences and placental transfer. CRC, Boca Raton, pp 181\u2013192"},{"key":"BF02072029_CR71","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF00570140","volume":"62","author":"H-J Schmahl","year":"1988","unstructured":"Schmahl H-J, Nau H, Neubert D (1988) The enantiomers of the teratogenic thalidomide analogue EM12. 1. Chiral inversion and plasma pharmacokinetics in the marmoset monkey. Arch Toxicol 62: 200\u2013204","journal-title":"Arch Toxicol"},{"key":"BF02072029_CR72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/tera.1420050213","volume":"5","author":"HJ Schumacher","year":"1970","unstructured":"Schumacher HJ, Terapane J, Jordan RL, Wilson JG (1970) The teratogenic activity of a thalidomide analogue, EM12, in rabbits, rats, and in monkeys. Teratology 5: 233\u2013240","journal-title":"Teratology"},{"key":"BF02072029_CR73","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000249960","volume":"165","author":"F Scolari","year":"1982","unstructured":"Scolari F, Harms M, Gilardi S (1982) La thalidomide dans le traitement du lupus \u00e9ryth\u00e9mateux chronique. Dermatologica 165: 355\u2013362","journal-title":"Dermatologica"},{"key":"BF02072029_CR74","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/tera.1420160313","volume":"16","author":"WJ Scott","year":"1977","unstructured":"Scott WJ, Fradkin R, Wilson JG (1977) Non-confirmation of thalidomide induced teratogenesis in rats and mice. Teratology 16: 333\u2013336","journal-title":"Teratology"},{"key":"BF02072029_CR75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/tera.1420220207","volume":"22","author":"WJ Scott","year":"1980","unstructured":"Scott WJ, Wilson JG, Helm FC (1980) A metabolite of a structural analogue of thalidomide lacks teratogenic effect in pregnant rhesus monkeys. Teratology 22: 183\u2013185","journal-title":"Teratology"},{"key":"BF02072029_CR76","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","volume":"6","author":"J Sheskin","year":"1965","unstructured":"Sheskin J (1965) Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6: 303\u2013306","journal-title":"Clin Pharmacol Ther"},{"key":"BF02072029_CR77","first-page":"1","volume":"26","author":"J Sheskin","year":"1975","unstructured":"Sheskin J (1975) Therapeutische Erfahrungen \u00fcber den Einflu\u00df des Thalidomids bei der Lepra Reaktion. Hautarzt 26: 1\u20135","journal-title":"Hautarzt"},{"key":"BF02072029_CR78","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-4362.1978.tb06052.x","volume":"17","author":"J Sheskin","year":"1978","unstructured":"Sheskin J (1978) Study with nine thalidomide derivatives in the lepra reaction. Int J Dermatol 17: 82\u201384","journal-title":"Int J Dermatol"},{"key":"BF02072029_CR79","first-page":"548","volume":"17","author":"J Sheskin","year":"1966","unstructured":"Sheskin J, Convit J (1966) Therapie der Lepra mit Thalidomid. Eine Doppelblind-Studie. Hautarzt 17: 548\u2013549","journal-title":"Hautarzt"},{"key":"BF02072029_CR80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/346425a0","volume":"346","author":"TA Springer","year":"1990","unstructured":"Springer TA (1990) Adhesion receptors of the immune system. Nature 346: 425\u2013434","journal-title":"Nature"},{"key":"BF02072029_CR81","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1073\/pnas.84.10.3239","volume":"84","author":"Y Takada","year":"1987","unstructured":"Takada Y, Strominger JL, Hemler ME (1987) The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis. PNAS (USA) 84: 3239\u20133243","journal-title":"PNAS (USA)"},{"key":"BF02072029_CR82","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00007890-198109000-00005","volume":"32","author":"PJ Tutschka","year":"1981","unstructured":"Tutschka PJ, Hess AD, Beschorner WE, Santos GW (1981) Suppressor cells in transplantation tolerance. 1. Suppressor cells in the mechanism of tolerance in radiation chimeras. Transplantation 32: 203\u2013209","journal-title":"Transplantation"},{"key":"BF02072029_CR83","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/00007890-198605000-00018","volume":"41","author":"GB Vogelsang","year":"1986","unstructured":"Vogelsang GB, Hess AD, Gordon G, Santos GW (1986) Treatment and prevention of acute graft-versus-host disease with thalidomide in a rat model. Transplantation 41: 644\u2013647","journal-title":"Transplantation"},{"key":"BF02072029_CR84","first-page":"2658","volume":"19","author":"GB Vogelsang","year":"1987","unstructured":"Vogelsang GB, Hess AD, Gordon G, Brundrette R, Santos GW (1987) Thalidomide induction of bone marrow transplantation tolerance. Transplant Proc 19: 2658\u20132661","journal-title":"Transplant Proc"},{"key":"BF02072029_CR85","first-page":"393","volume":"3","author":"GB Vogelsang","year":"1988","unstructured":"Vogelsang GB, Hess AD, Santos GW (1988 a) Thalidomide for treatment of graft-versus-host disease. Bone Marrow Transplant 3: 393\u2013398","journal-title":"Bone Marrow Transplant"},{"key":"BF02072029_CR86","first-page":"904","volume":"18","author":"GB Vogelsang","year":"1986","unstructured":"Vogelsang GB, Taylor S, Gordon G, Hess AD (1986 b) Thalidomide, a potent agent for the treatment of graft-versus-host disease. Transplant Proc 18: 904\u2013906","journal-title":"Transplant Proc"},{"key":"BF02072029_CR87","doi-asserted-by":"crossref","first-page":"055","DOI":"10.1056\/NEJM199204163261604","volume":"326","author":"GB Vogelsang","year":"1992","unstructured":"Vogelsang GB, Farmer ER, Hess AD, Altamonte V, Beschorner WE, Jabs DA, Corio RL, Levin LS, Colvin OM, Wingard JR, Santos GW (1992) Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med 326: 055\u20131058","journal-title":"N Engl J Med"},{"key":"BF02072029_CR88","first-page":"1863","volume":"37","author":"HR Wiedemann","year":"1961","unstructured":"Wiedemann HR (1961) Hinweis auf eine derzeitige H\u00e4ufung hypo und aplastischer Fehlbildungen der Gliedma\u00dfen. Med Welt 37: 1863\u20131866","journal-title":"Med Welt"},{"key":"BF02072029_CR89","volume-title":"Klinik und Pathologie der Dysmelie","author":"HG Willen","year":"1969","unstructured":"Willen HG, Henkel HL (1969) Klinik und Pathologie der Dysmelie. Springer, Berlin Heidelberg New York"},{"key":"BF02072029_CR90","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2133.1985.tb02323.x","volume":"112","author":"CH Wulff","year":"1985","unstructured":"Wulff CH, H\u00f8yer H, Asboe-Hansen G, Brodthagen H (1985) Development of polyneuropathy during thalidomide therapy. Br J Dermatol 112: 475\u2013480","journal-title":"Br J Dermatol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02072029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02072029\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02072029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T05:56:33Z","timestamp":1683179793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02072029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF02072029"],"URL":"https:\/\/doi.org\/10.1007\/bf02072029","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}